Effect of Caudal Nalbuphine on Postoperative Analgesia in Children
NCT ID: NCT02618876
Last Updated: 2020-04-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2015-11-30
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
2 groups, 30 patients each
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nalbuphine as an Adjuvant to Levobupivacaine in Caudal Analgesia in Children
NCT05617976
Effect of Caudal Nalbuphine on Postoperative Emergence Agitation in Pediatrics Undergoing Infra-umbilical Surgeries
NCT05245721
Spinal Versus Caudal Analgesia After Pediatric Infra-umbilical Surgery
NCT02988700
Topical Ketamine Versus Caudal Ketamine for Postoperative Analgesia in Children Undergoing Inguinal Herniotomy
NCT02462174
Nalbuphine as an Adjuvant to Intravenous Regional Anesthesia
NCT02678585
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nalbuphine group
30 children will be given Caudal Bupivacaine plus Nalbuphine.
Nalbuphine plus Bupivacaine
Addition of caudal Nalbuphine to the standard Bupivacaine
Control group
30 children will be given Caudal Bupivacaine.
Bupivacaine
Caudal Bupivacaine is the standard of care will be considered as a control
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nalbuphine plus Bupivacaine
Addition of caudal Nalbuphine to the standard Bupivacaine
Bupivacaine
Caudal Bupivacaine is the standard of care will be considered as a control
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with American Society of Anesthesiologists (ASA) physical status I
* age 2-10 years
Exclusion Criteria
* allergy to study medications
* major malformations of the lower spine or meninges or any cutaneous or subcutaneous lesion at the site of injection.
2 Years
10 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Bakri
Associate professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assiut University Hospital
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB 000087145
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.